ConductScience.org, home

Paper86392

Bleomycin pharmacokinetics in man. I. Intravenous administration.

Alberts DS and 9 others. Cancer Chemother Pharmacol, 1978. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Bleomycin pharmacokinetics in man. I. Intravenous administration. Papers, record 86392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/86392

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bleomycin pharmacokinetics in man. I. Intravenous administration.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
2.6
iCite
Revised in PubMed
2019-08-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alberts DSD S
2Chen HSH S
3Liu RR
4Himmelstein KJK J
5Mayersohn MM
6Perrier DD
7Gross JJ
8Moon TT
9Broughton AA
10Salmon SES E

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
Adult
Aged
Female
Humans
Injections, Intravenous
Kinetics
Male
Middle Aged
Neoplasms
Radioimmunoassay
Time Factors

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14122362A clinical review of bleomycin--a new antineoplastic agent.Cancer1973https://conductscience.org/library/papers/4122362PubMed
266973Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal function.Cancer1977https://conductscience.org/library/papers/66973PubMed
35953301New antibiotics, bleomycin A and B.J Antibiot (Tokyo)1966https://conductscience.org/library/papers/5953301PubMed
474282Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.Cancer Treat Rep1977https://conductscience.org/library/papers/74282PubMed
562609Intracavitary bleomycin in the management of malignant effusions.Cancer1976https://conductscience.org/library/papers/62609PubMed
64132697Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.Cancer1974https://conductscience.org/library/papers/4132697PubMed
7134142CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.J Pharm Sci1976https://conductscience.org/library/papers/134142PubMed
84131335Letter: New components of bleomycin.J Antibiot (Tokyo)1973https://conductscience.org/library/papers/4131335PubMed
94427218Statistical estimations in pharmacokinetics.J Pharmacokinet Biopharm1974https://conductscience.org/library/papers/4427218PubMed
104131336Letter: Chemistry of bleomycin. XI. The structures of the terminal amines.J Antibiot (Tokyo)1973https://conductscience.org/library/papers/4131336PubMed
1172602Specificity of antisera produced against bleomycin.Cancer Treat Rep1977https://conductscience.org/library/papers/72602PubMed
1256999Radioimmunoassay of bleomycin.Cancer Res1976https://conductscience.org/library/papers/56999PubMed
134118759Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients.Ann Intern Med1972https://conductscience.org/library/papers/4118759PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
29734689The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA.Int J Mol Sci2018https://conductscience.org/library/papers/29734689PubMed
28160575Safety and efficacy of bleomycin/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system.Oncotarget2017https://conductscience.org/library/papers/28160575PubMed
25590623Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.PLoS One2015https://conductscience.org/library/papers/25590623PubMed
23450195Tumor size and effectiveness of electrochemotherapy.Radiol Oncol2013https://conductscience.org/library/papers/23450195PubMed
16012866Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge.J Cancer Res Clin Oncol2005https://conductscience.org/library/papers/16012866PubMed
7318146Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318146PubMed
6207949Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6207949PubMed
6189661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
6155927Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.Br J Cancer1980https://conductscience.org/library/papers/6155927PubMed
6088712Chemosensitivity of malignant human brain tumors. Preliminary results.J Neurooncol1983https://conductscience.org/library/papers/6088712PubMed
4053266In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4053266PubMed
4039488Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.Urol Res1985https://conductscience.org/library/papers/4039488PubMed
3555940Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet1987https://conductscience.org/library/papers/3555940PubMed
3054425Clinical management of cytotoxic drug overdose.Med Toxicol Adverse Drug Exp1988https://conductscience.org/library/papers/3054425PubMed
2443992Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.Thorax1987https://conductscience.org/library/papers/2443992PubMed
2426030Pharmacokinetic drug interactions of commonly used anticancer drugs.Clin Pharmacokinet1986https://conductscience.org/library/papers/2426030PubMed
1711838Mechanisms of bleomycin-induced lung damage.Arch Toxicol1991https://conductscience.org/library/papers/1711838PubMed
1696567Phase I trial of tallysomycin S10b, a bleomycin analogue.Invest New Drugs1990https://conductscience.org/library/papers/1696567PubMed
93987Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/93987PubMed
93985Bleomycin pharmacokinetics in man. II. Intracavitary administration.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/93985PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/86392

GET https://conductscience.org/api/papers/v1/86392/authors